Real-Time PCR, Digital PCR And End-Point PCR Global Market Analysis, Trends, Growth, Research And Forecast 2033

The new report published by The Business Research Company, titled "Real-Time PCR, Digital PCR And End-Point PCR Global Market Report 2024 - Market Size, Trends, And Global Forecast 2024-2033", delivers an in-depth analysis of the leading size and forecasts, investment opportunities, winning strategies, market drivers and trends, competitive landscape, and evolving market trends.

As per the report, the real-time pcr, digital pcr and end-point pcr market size has grown strongly in recent years. It will grow from $35.11 billion in 2023 to $38.37 billion in 2024 at a compound annual growth rate (CAGR) of 9.3%. The real-time pcr, digital pcr and end-point pcr market size is expected to see strong growth in the next few years. It will grow to $54.95 billion in 2028 at a compound annual growth rate (CAGR) of 9.4%.

Download Free Sample Report @ https://www.thebusinessresearchcompany.com/sample.aspx?id=13296&type=smp

Elevated Prevalence Of Infectious Diseases Fueling Growth In The Real-Time Pcr, Digital Pcr, And End-Point Pcr Market
The increase in the incidence of infectious diseases is expected to propel the growth of the real-time PCR, digital PCR, and end-point PCR markets going forward. Infectious diseases refer to illnesses caused by the invasion and multiplication of pathogenic microorganisms, including bacteria, viruses, fungi, and parasites. Real-time PCR, digital PCR, and end-point PCR are utilized in infectious diseases to quantify specific pathogens or their genetic material, monitor disease progression, and rapidly diagnose infections such as HIV, hepatitis, respiratory viruses, and tuberculosis. For instance, in July 2023, according to UNAIDS, the Switzerland-based UN program dedicated to addressing the global HIV/AIDS epidemic, the global population living with HIV increased to 39 million in 2022, up 3.17% from 37.7 million in 2020. Moreover, there were approximately 1.3 million new HIV infections reported in 2022. Furthermore, in March 2023, according to the Centers for Disease Control and Prevention, a US-based national public health organization, in the United States, 8,300 cases of tuberculosis (TB) were reported in 2022, a rise from 7,874 cases in 2021. Therefore, the increase in the incidence of infectious diseases will drive the growth of the cephalosporin market.

Innovative Advances In Digital Pcr Technology Transforming The Real-Time Pcr Market
Major companies operating in the real-time PCR, digital PCR, and end-point PCR markets are developing innovative products using advanced technologies such as digital polymerase chain reaction (dPCR) technology to better understand the nature of a patient's cancer, genetic disease, or infection. Digital polymerase chain reaction (dPCR) technology is a biotechnological refinement of conventional polymerase chain reaction (PCR) methods that can directly quantify and clonally amplify nucleic acid strands, including DNA, cDNA, or RNA. For instance, in August 2022, Roche Diagnostics, a US-based manufacturer of medicines and medical devices, launched the next-generation digital PCR Digital LightCycler System for early detection and treatment of various chronic and genetic disorders. The system is designed to automate workflow and manage data, eliminating the need for external calculations, software, and processors. A combination of three nano well plate configurations, six advanced optical channels, and 5x concentrated DNA and RNA master mixes provides high sensitivity and precision. The Digital LightCycler System is a valuable addition to Roche's portfolio of diagnostic platforms, providing advanced technology, clinical applications, customization and flexibility, and workflow automation.

The real-time pcr, digital pcr and end-point pcr market covered in this report is segmented -

1) By Product: Instruments, Consumables And Reagents, Software And Services
2) By Technology: Quantitative, End-Point Polymerase Chain Reaction (PCR), Digital
3) By Applications: Clinical, Research, Forensic, Other Applications
4) By End User: Hospital, Diagnostic Labs, Pharma, Biotech, Contract Research Organizations

Buy Now & Get Exclusive Discount on this Report, Checkout link @
https://www.thebusinessresearchcompany.com/Discount?id=13296&type=discount

Major companies operating in the real-time pcr, digital pcr and end-point pcr market report are F. Hoffmann La Roche Ltd., Merck & Co. Inc., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Becton Dickinson and Co., GE HealthCare Technologies Inc., Agilent Technologies Inc., bioMérieux S.A., Bio-Rad Laboratories Inc., QIAGEN N.V., Eppendorf Group, Promega Corporation, Meridian Bioscience Inc., Takara Bio Inc. , Cole-Parmer Instrument Company LLC, Bioneer Corporation, Enzo Life Sciences Inc., Analytik Jena AG , Fluidigm Corporation, Elitech Group SAS, Microsynth AG, Stilla Technologies SAS, HTG Molecular Diagnostics Inc., AITbiotech Pte Ltd., Bio Molecular Systems, JN Medsys Pte Ltd., Biomeme Inc.

Contents of the report:
1. Executive Summary
2. Real-Time PCR, Digital PCR And End-Point PCR Market Report Structure
3. Real-Time PCR, Digital PCR And End-Point PCR Market Trends And Strategies
4. Real-Time PCR, Digital PCR And End-Point PCR Market - Macro Economic Scenario
5. Real-Time PCR, Digital PCR And End-Point PCR Market Size And Growth
…..
27. Real-Time PCR, Digital PCR And End-Point PCR Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Explore the report store to make a direct purchase of the report @ https://www.thebusinessresearchcompany.com/report/real-time-pcr-digital-pcr-and-end-point-pcr-global-market-report

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company

The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.

This release was published on openPR.